Cara Swisher talks with Weight Watchers CEO Seema Sustani about the company's plans to buy sequence, a telehealth company that prescribes GLP1 drugs. Cara also shows off her all-electric Chevy Bold EV and explains why she loves it so much. The full interview will be on Pivot next Monday at 9 p.m. ET.
WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventions? We ask our guest, WeightWatchers CEO Sima Sistani. Before and after the interview, Nayeema and Kara discuss their own experiences with diet fads and whether drugs like Wegovy and Ozempic will help America deal with the obesity epidemic or simply avoid tackling underlying issues like food supply, corporate greed and light regulation.
Questions? Comments? Email us at on@voxmedia.com or find us on Twitter @karaswisher and @nayeema
Learn more about your ad choices. Visit podcastchoices.com/adchoices